Centiva Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,300
Closed -$2.6M 1874
2022
Q3
$2.6M Buy
+50,300
New +$2.08M 0.05% 286
2021
Q2
Sell
-11,446
Closed -$586K 1833
2021
Q1
$586K Buy
+11,446
New +$689K 0.02% 505
2020
Q3
Sell
-14,230
Closed -$819K 921
2020
Q2
$819K Buy
+14,230
New +$774K 0.05% 207

Other funds holding CCXI

Centiva Capital's CCXI Position: Q4 2022 in Review

Centiva Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 50,300 shares — an estimated $2.6M sold.

Centiva Capital first reported a position in CCXI in Q2 2020 and held it in 3 quarters. The position peaked at $2.6M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Centiva Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 50,300 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.6M.
  • Centiva Capital first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 3 quarters.
  • Centiva Capital's ChemoCentryx, Inc. position peaked at $2.6M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.